| Migraine and the trigeminovascular system—40 years and counting M Ashina, JM Hansen, TP Do, A Melo-Carrillo, R Burstein, MA Moskowitz The Lancet Neurology 18 (8), 795-804, 2019 | 443 | 2019 |
| Cortical spreading depression closes paravascular space and impairs glymphatic flow: implications for migraine headache AJ Schain, A Melo-Carrillo, AM Strassman, R Burstein Journal of Neuroscience 37 (11), 2904-2915, 2017 | 228 | 2017 |
| Fremanezumab—a humanized monoclonal anti-CGRP antibody—inhibits thinly myelinated (Aδ) but not unmyelinated (C) meningeal nociceptors A Melo-Carrillo, AM Strassman, RR Nir, AJ Schain, R Noseda, J Stratton, ... Journal of Neuroscience 37 (44), 10587-10596, 2017 | 199 | 2017 |
| Selective inhibition of trigeminovascular neurons by fremanezumab: a humanized monoclonal anti-CGRP antibody A Melo-Carrillo, R Noseda, RR Nir, AJ Schain, J Stratton, AM Strassman, ... Journal of Neuroscience 37 (30), 7149-7163, 2017 | 141 | 2017 |
| A chronic animal model of migraine, induced by repeated meningeal nociception, characterized by a behavioral and pharmacological approach A Melo-Carrillo, A Lopez-Avila Cephalalgia 33 (13), 1096-1105, 2013 | 116 | 2013 |
| Depressive symptoms among Mexican medical students: High prevalence and the effect of a group psychoeducation intervention A Melo-Carrillo, L Van Oudenhove, A Lopez-Avila Journal of affective disorders 136 (3), 1098-1103, 2012 | 104 | 2012 |
| Fluorescently-labeled fremanezumab is distributed to sensory and autonomic ganglia and the dura but not to the brain of rats with uncompromised blood brain barrier R Noseda, AJ Schain, A Melo-Carrillo, J Tien, J Stratton, F Mai, ... Cephalalgia 40 (3), 229-240, 2020 | 78 | 2020 |
| Activation of pial and dural macrophages and dendritic cells by cortical spreading depression AJ Schain, A Melo‐Carrillo, D Borsook, J Grutzendler, AM Strassman, ... Annals of neurology 83 (3), 508-521, 2018 | 77 | 2018 |
| Non-trigeminal nociceptive innervation of the posterior dura: implications to occipital headache R Noseda, A Melo-Carrillo, RR Nir, AM Strassman, R Burstein Journal of Neuroscience 39 (10), 1867-1880, 2019 | 67 | 2019 |
| CSD-induced arterial dilatation and plasma protein extravasation are unaffected by fremanezumab: implications for CGRP's role in migraine with aura AJ Schain, A Melo-Carrillo, J Stratton, AM Strassman, R Burstein Journal of Neuroscience 39 (30), 6001-6011, 2019 | 63 | 2019 |
| Exploring the effects of extracranial injections of botulinum toxin type A on prolonged intracranial meningeal nociceptors responses to cortical spreading depression in female rats A Melo-Carrillo, AM Strassman, AJ Schain, R Noseda, S Ashina, A Adams, ... Cephalalgia 39 (11), 1358-1365, 2019 | 35 | 2019 |
| Fremanezumab and its isotype slow propagation rate and shorten cortical recovery period but do not prevent occurrence of cortical spreading depression in rats with compromised … A Melo-Carrillo, AJ Schain, J Stratton, AM Strassman, R Burstein Pain 161 (5), 1037-1043, 2020 | 33 | 2020 |
| Combined onabotulinumtoxinA/atogepant treatment blocks activation/sensitization of high-threshold and wide-dynamic range neurons A Melo-Carrillo, AM Strassman, AJ Schain, AM Adams, MF Brin, ... Cephalalgia 41 (1), 17-32, 2021 | 29 | 2021 |
| OnabotulinumtoxinA alters inflammatory gene expression and immune cells in chronic headache patients L Gfrerer, W Xu, W Austen Jr, S Ashina, A Melo-Carrillo, MS Longhi, ... Brain 145 (7), 2436-2449, 2022 | 25 | 2022 |
| Pre-treatment non-ictal cephalic allodynia identifies responders to prophylactic treatment of chronic and episodic migraine patients with galcanezumab: a prospective … S Ashina, A Melo-Carrillo, E Szabo, D Borsook, R Burstein Cephalalgia 43 (3), 03331024221147881, 2023 | 24 | 2023 |
| Unrecognized challenges of treating status migrainosus: An observational study A Iljazi, A Chua, R Rich-Fiondella, M Veronesi, A Melo-Carrillo, S Ashina, ... Cephalalgia 40 (8), 818-827, 2020 | 23 | 2020 |
| Atogepant–an orally-administered CGRP antagonist–attenuates activation of meningeal nociceptors by CSD AM Strassman, A Melo-Carrillo, TT Houle, A Adams, MF Brin, R Burstein Cephalalgia 42 (9), 933-943, 2022 | 19 | 2022 |
| Galcanezumab effects on incidence of headache after occurrence of triggers, premonitory symptoms, and aura in responders, non-responders, super-responders, and super non-responders S Ashina, A Melo-Carrillo, A Toluwanimi, N Bolo, E Szabo, D Borsook, ... The Journal of Headache and Pain 24 (1), 26, 2023 | 17 | 2023 |
| Neck pain and headache: Pathophysiology, treatments and future directions HM Al-Khazali, LS Krøll, H Ashina, A Melo-Carrillo, R Burstein, FM Amin, ... Musculoskeletal Science and Practice 66, 102804, 2023 | 13 | 2023 |
| Celecoxib reduces cortical spreading depression–induced macrophage activation and dilatation of dural but not pial arteries in rodents: implications for mechanism of action in … AJ Schain, A Melo-Carrillo, S Ashina, AM Strassman, R Burstein Pain 161 (5), 1019-1026, 2020 | 13 | 2020 |
